-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Updates on the Diagnosis and Management of the Most Common Porphyrias – AIP and EPP

Program: Education Program
Session: Anxiety Provoking Hematology Consults, Second Edition
Hematology Disease Topics & Pathways:
Biological, Diseases, Therapies, Combinations, Genetic Disorders, enzyme inhibitors, Biological Processes, erythropoiesis, Clinically relevant, pathogenesis, pathways
Saturday, December 5, 2020, 11:55 AM-12:00 PM

Michael Linenberger, MD

Seattle Cancer Care Alliance, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA

Disclosures: No relevant conflicts of interest to declare.

OffLabel Disclosure:

See more of: Anxiety Provoking Hematology Consults, Second Edition
See more of: Education Program
<< Previous Presentation | Next Presentation >>